Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学BCMA CAR-T, Multiple Myeloma

Madhav Dhodapkar

MBBS

🏢Winship Cancer Institute, Emory University🌐USA

Chief of Hematology/Oncology

62
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Madhav Dhodapkar at Emory University is a leader in myeloma immunology and CAR-T therapy, with expertise in BCMA-targeted and GPRC5D-targeted CAR-T products. He has contributed to understanding immune surveillance failure in myeloma and how antigen heterogeneity contributes to relapse after CAR-T therapy. His translational work informs combination strategies to extend durability of responses.

Share:

🧪Research Fields 研究领域

BCMA CAR-T myeloma
GPRC5D CART
myeloma immunotherapy
immune surveillance myeloma
tumor antigen heterogeneity myeloma

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Madhav Dhodapkar 的研究动态

Follow Madhav Dhodapkar's research updates

留下邮箱,当我们发布与 Madhav Dhodapkar(Winship Cancer Institute, Emory University)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment